Cargando…
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
IMPORTANCE: Moving to multigene testing for all women with breast cancer (BC) could identify many more mutation carriers who can benefit from precision prevention. However, the cost-effectiveness of this approach remains unaddressed. OBJECTIVE: To estimate incremental lifetime effects, costs, and co...
Autores principales: | Sun, Li, Brentnall, Adam, Patel, Shreeya, Buist, Diana S. M., Bowles, Erin J. A., Evans, D. Gareth R., Eccles, Diana, Hopper, John, Li, Shuai, Southey, Melissa, Duffy, Stephen, Cuzick, Jack, dos Santos Silva, Isabel, Miners, Alec, Sadique, Zia, Yang, Li, Legood, Rosa, Manchanda, Ranjit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777250/ https://www.ncbi.nlm.nih.gov/pubmed/31580391 http://dx.doi.org/10.1001/jamaoncol.2019.3323 |
Ejemplares similares
-
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density
por: Brentnall, Adam R., et al.
Publicado: (2018) -
Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China
por: Sun, Li, et al.
Publicado: (2022) -
Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems
por: Manchanda, Ranjit, et al.
Publicado: (2020) -
Development and evaluation of a method to assess breast cancer risk using a longitudinal history of mammographic density: a cohort study
por: Atakpa, Emma C., et al.
Publicado: (2023) -
Population based germline testing for primary cancer prevention
por: Manchanda, Ranjit, et al.
Publicado: (2018)